Home / Inspections / 1119410

FDA Inspection 1119410 — Recipharm Pharmaservices Private Limited

Recipharm Pharmaservices Private Limited — FEI 3009150119

The FDA completed an inspection of Recipharm Pharmaservices Private Limited on February 13, 2020 in Bengaluru. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 13, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bengaluru (India)

Citations

IDCFRDescription
127421 CFR 211.68(a)Calibration/Inspection/Checking not done

Facility

Other inspections at this facility

  • 1232473 (NAI Fri Mar 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1079034 (VAI Fri Feb 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1053644 (NAI Fri May 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 921695 (NAI Thu Mar 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 805946 (VAI Thu Nov 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources